352940 — Enbio Co Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsAdventurousMicro CapNeutral

Annual income statement for Enbio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	34,563	33,466	34,240	34,024	35,654
Cost of Revenue
Gross Profit	14,505	10,968	6,585	7,237	11,795
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	30,688	32,735	39,262	39,351	34,568
Operating Profit	3,875	731	-5,022	-5,327	1,086
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-4,966	6,128	-3,832	-8,060	885
Provision for Income Taxes
Net Income After Taxes	-4,449	5,245	-3,445	-6,300	646
Net Income Before Extraordinary Items
Net Income	-4,449	5,245	-3,445	-6,300	646
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-4,449	5,245	-3,445	-6,300	646
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-522	514	-302	-417	52.4
Dividends per Share